Table 2. T clinical staging of the groups studied.
| Clinical staging | Group 1 | Group 2 |
|---|---|---|
| T2a | 50 | 51 |
| T2b | 14 | 13 |
| T2c | 16 | 16.5 |
| T3a | 11 | 11.5 |
| T3b | 9 | 8 |
Results expressed as %.
| Clinical staging | Group 1 | Group 2 |
|---|---|---|
| T2a | 50 | 51 |
| T2b | 14 | 13 |
| T2c | 16 | 16.5 |
| T3a | 11 | 11.5 |
| T3b | 9 | 8 |
Results expressed as %.